Merck, Xenon in cardiovascular deal

Merck & Co. Inc. (NYSE:MRK) and Xenon Pharmaceuticals Inc. (Vancouver, B.C.) partnered to discover and develop small molecules to treat cardiovascular disease. Xenon will perform drug discovery and pr...